Product Description: IDE-IN-3 (Compound 4) is an inhibitor for insulin-degrading enzyme. IDE-IN-3 is predicted to have CYP3A4, CYP2C19, hERG, NADP+, HIF1α and histidine kinase inhibitory activities, and has potential biological activity in anti-diabetic, anti-tumor, anti-bacterial aspects, according to the in silico prediction[1].
Applications: Metabolism-protein/nucleotide metabolism
Formula: C13H12O3
References: [1]Saif MZ, et al., Investigating the potential of 6-substituted 3-formyl chromone derivatives as anti-diabetic agents using in silico methods. Sci Rep. 2024 Jun 8;14(1):13221.
CAS Number: 49619-58-1
Molecular Weight: 216.23
Compound Purity: 98.04
Research Area: Cancer; Infection; Metabolic Disease
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: Proteolytic Enzyme